Cite
HARVARD Citation
Statland, J. et al. (2022). Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy. Muscle & nerve. 66 (1), pp. 50-62. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Statland, J. et al. (2022). Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy. Muscle & nerve. 66 (1), pp. 50-62. [Online].